{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigygynlis43lqnx2addj6gm4gh2zukp3ixpuyb6hj632jju4bk5em",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mkb3lrgnfks2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibdma6cjwyn2owhxhanv4xm4jxnuh6ao34tlo2u5f4wgnijmpi6pm"
    },
    "mimeType": "image/jpeg",
    "size": 1286035
  },
  "path": "/news/2026-04-exploiting-vulnerability-zombie-cells-anticancer.html",
  "publishedAt": "2026-04-24T12:00:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new set of drugs exploit a recently revealed weakness in \"zombie-like\"—or senescent—cells that could lead to new treatments for cancer and age-associated diseases. The study from the MRC Laboratory of Medical Sciences (LMS) and Imperial College London shows that senescent cells walk a tightrope, risking cell death with high levels of iron and other damaging agents but compensating for this by overproducing a protective protein that staves off death.",
  "title": "Exploiting a new vulnerability that targets 'zombie' cells as an anticancer therapy"
}